1 Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.

2 Validation of SARS-CoV-2 detection across multiple specimen types.

3 urine test strips to exclude cerebral spinal fluid blood

4 serta domain containing protein 1 (sertad1) interacts with classical swine fever virus structural glycoprotein e2, which is involved in virus virulence in swine

5 erp implementation and interoperability growth as organization improvement agents in public administration further development

6 oligoclonal igg bands in the cerebrospinal fluid of portuguese patients with multiple sclerosis: negative results indicate benign disease bandas oligoclonais da igg no líquido céfalo-raquidiano de doentes portugueses com esclerose múltipla: resultados negativos indicam doença benigna

7 contrast sensitivity to angular frequency stimuli is higher than that for sinewave gratings in the respective middle range

8 commentary: csf and plasma testosterone in attempted suicide

9 Isoelectric point restriction of cerebrospinal fluid and serum IgG antibodies to measles virus polypeptides in multiple sclerosis

10 Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

11 Form follows function: estimation of CSF flow in the third ventricle-aqueduct-fourth ventricle complex modeled as a diffuser/nozzle pump.

12 Kaposi Sarcoma Herpes Virus (KSHV) infection inhibits macrophage formation and survival by counteracting Macrophage Colony-Stimulating Factor (M-CSF)-induced increase of Reactive Oxygen Species (ROS), c-Jun N-terminal kinase (JNK) phosphorylation and autophagy

13 Immunochromatography in CSF improves data on surveillance of S. pneumoniae meningitis in India.

14 Chimeric G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient induction of Cardiomyocytes from Mouse Induced Pluripotent Stem Cells.

15 Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model

16 Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.

17 Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia.

18 Estimation of Dosimetric Parameters based on KNR and KNCSF Correction Factors for Small Field Radiation Therapy at 6 and 18 MV Linac Energies using Monte Carlo Simulation Methods

19 Corrigenda: Prophylactic allergen immunotherapy with Der p 2 prevents murine asthma by regulating lung GM-CSF (The Journal of Allergy and Clinical Immunology (2019) 143(6) (2307–2311.e5), (S0091674919302672), (10.1016/j.jaci.2019.02.007))

20 Impairment of G-CSF receptor on granulocytic progenitor cells causes neutropenia in protein malnutrition

21 Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.

22 Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer's disease spectrum.

23 Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.

24 Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.

25 Liver fibrosis and CD206 macrophage accumulation are suppressed by anti-GM-CSF therapy.

26 Correlation of spontaneous and traumatic anterior skull base CSF leak flow rates with fluid pattern on early, delayed, and subtraction volumetric extended echo train T2-weighted MRI.

27 Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.

28 Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.

29 CSF omeprazole concentration and albumin quotient following high dose intravenous omeprazole in dogs.

30 Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.

31 Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers.

32 Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation.

33 Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer

34 Evaluation of CSF leaks: high-resolution CT compared with contrast-enhanced CT and radionuclide cisternography

35 Incidence of bacterial meningitis in Asia using enhanced CSF testing: polymerase chain reaction, latex agglutination and culture

36 Predictive Value of Cerebrospinal Fluid (CSF) Lactate Level Versus CSF/Blood Glucose Ratio for the Diagnosis of Bacterial Meningitis Following Neurosurgery

37 Incidence of bacterial meningitis in Asia using enhanced CSF testing: polymerase chain reaction, latex agglutination and culture

38 island latissimus dorsi muscle flap and a perforator flap in repairing post-gunshot thoracic spine csf fistula: case presentation

39 the levels of soluble receptor of tumor necrosis factor p55, tnf, neutrophil-derived alpha-defensins and both isoforms of interleukin-8 in the blood and cerebrospinal fluid (csf) from children with generalized forms of meningococcal infection

40 hochuekkito, a kampo (traditional japanese herbal) medicine, and its polysaccharide portion stimulate g-csf secretion from intestinal epithelial cells

41 can csf spectrophotometry for “xanthochromia” be used to detect leaking subarachnoid aneurysms in patients with sickle cell anemia with negative mri or ct angiogram despite hyperbilirubinemia?

42 long-term outcome after autologous stem cell transplantation with adequate peripheral blood stem cell mobilization using plerixafor and g-csf in poor mobilizer lymphoma and myeloma patients

43 gm-csf exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients

44 when cognitive decline and depression coexist in the elderly: csf biomarkers analysis can differentiate alzheimer's disease from late-life depression

45 case report: csf pseudocyst in the breast

46 m-csf and gm-csf regulation of stat5 activation and dna binding in myeloid cell differentiation is disrupted in nonobese diabetic mice

47 trabalho de consenso de força-tarefa da wfsbp sobre marcadores biológicos das demências: contribuição da análise do lcr e do sangue para o diagnóstico precoce e diferencial das demências consensus paper of the wfsbp task force on biological markers of dementia: the role of csf and blood analysis in the early and differential diagnosis of dementia (world j biol psychiatry. 2005;6(2):69-84. review)

48 autosomal dominant alzheimer disease: a unique resource to study csf biomarker changes in preclinical ad

49 creb regulates tnf-α-induced gm-csf secretion via p38 mapk in human lung fibroblasts

50 cryptococcal/csf ventricular levels on mri brain in a man with aids

51 comparison of two analytical platforms for csf biomarkers of alzheimer’s disease

52 a dna vaccine encoding mutated hpv58 me6e7-fc-gpi fusion antigen and gm-csf and b7.1

53 therapy of an incomplete spinal cord injury by intrathecal injection of epo and subcutaneous injection of epo, vitamin c and g-csf

54 enhanced immune response of a bicistronic dna vaccine expressing fusion antigen hsp65-esat-6 of mycobacterium tuberculosis with gm-csf as a molecular adjuvant

55 protective role of myeloid cells expressing a g-csf receptor polymorphism in an induced model of lupus

56 camp analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (gm-csf) in human bone marrow stromal cells in vitro

57 exploring synergy in combinations of tumor-derived vaccines that harbor 4-1bbl, ox40l, and gm-csf

58 the establishment of a csf-contacting nucleus “knockout” model animal

59 s100β levels in csf of nonambulatory dogs with intervertebral disk disease treated with electroacupuncture

60 recurrent csf rhinorrhea misdiagnosed as chronic allergic rhinitis with subsequent development of bacterial meningitis

61 transmembrane amyloid-related proteins in csf as potential biomarkers for alzheimer’s disease

62 improving csf biomarkers’ performance for predicting progression from mild cognitive impairment to alzheimer’s disease: a meta-analysis

63 modulación de la expresión de la l-selectina por agentes quimiotácticos y gm-csf

64 which clinical parameters predict a positive csf diagnosis of meningitis in a population with high hiv prevalence?

65 potential of g-csf supplementation to counter the neutrophil effects of standard peg-ifnα plus ribavirin combination therapy for treating hcv-related cirrhosis

66 Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy

67 Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?

68 G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?

69 Use of G-CSF in a patient with hunter syndrome receiving bone marrow transplantation

70 Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

71 Measurement of CSF α‐synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer’s disease

72 Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?

73 Role of SPAK-NKCC1 signaling cascade in the choroid plexus blood-CSF barrier damage after stroke.

74 Small peptide CSF fingerprint of amyotrophic lateral sclerosis.

Keyword Connections

Journals

Research Groups

Bibliographies